Vincerx Pharma Announces Redemption of Public Warrants
PALO ALTO, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) (the “Company”), today announced that it...
Staff
Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company...
AEON Biopharma Doses First Patient in Phase 2 Trial of ABP-450 for the Treatment of Cervical Dystonia
-Topline data expected in early-2022-NEWPORT BEACH, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc., a private clinical-stage biopharmaceutical...
89bio Announces Plans for Phase 2b (ENLIVEN) Trial in NASH
- Received written guidance from FDA related to trial design and agreement to use liquid formulation -- ENLIVEN trial to...
CymaBay Appoints Thomas Wiggans and Janet Dorling to Board of Directors
NEWARK, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing...
Revo Health selects Allscripts® Practice Management
Management services organization partners with Allscripts to offer robust financial and scheduling platform to its clinics CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare, LLC...
Concerns about alcohol-based sanitisers are changing the way hospitals invest in protecting their staff
MANCHESTER, UK, April 04, 2021 (GLOBE NEWSWIRE) -- As concern around the health risks of alcohol-based sanitiser grows, more hospitals...
Termination of the business combination with Second Sight Medical Products, Inc.
Termination of the business combination with Second Sight Medical Products, Inc. Paris, France, April 3, 2021 – Considering the private...
Supernus Announces FDA Approval of Qelbree™ (SPN-812) for the Treatment of ADHD
Qelbree (viloxazine extended-release capsules) represents the first novel non-stimulant treatment for ADHD in a decade Supernus plans to make Qelbree...
Termination of the business combination with Second Sight Medical Products, Inc.
Termination of the business combination with Second Sight Medical Products, Inc. Paris, France, April 3, 2021 – Considering the private...
DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directors
Montrouge, France, April 2, 2021DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directors DBV Technologies (Euronext: DBV...
Emergent BioSolutions Announces Topline Data from NIAID Phase 3 ITAC Trial (INSIGHT-013) Evaluating Immunoglobulins as a Treatment for Hospitalized Patients with COVID-19
GAITHERSBURG, Md., April 02, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today provided an update on the evaluation of...
WW International Announces Refinancing Of Debt Maturities
NEW YORK, April 02, 2021 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (the “Company”) announced today that it has...
SmileDirectClub Announces Appointment of Ted Ward to Board of Directors
AdAge Power Player Brings to Company’s Board More Than Three Decades of Marketing Expertise as GEICO CMONASHVILLE, Tenn., April 02,...
Allarity Therapeutics Submits Premarket Approval Application to U.S. FDA for DRP® Companion Diagnostic for Dovitinib
- Submission precedes expected NDA filing for dovitinib in 2021 - Premarket Approval will allow U.S. marketing of DRP-Dovitinib as...
Coloplast A/S – Trading in Coloplast shares by board members, executives or associated persons
Please see enclosed pdf. Attachment 02042021_trading_in_shares_ARA
NKMax America Announces Corporate Name Change to NKGen Biotech
SANTA ANA, Calif., April 02, 2021 (GLOBE NEWSWIRE) -- NKMax America, a biotechnology company harnessing the power of the body's...
Nyxoah to Delay Full Year 2020 Earnings Release Until April 9, 2021
Nyxoah to Delay Full Year 2020 Earnings Release Until April 9, 2021 Mont-Saint-Guibert, Belgium – 2 April 2021 – Nyxoah...
Monthly information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2021
Monthly information regarding the total number of voting rights and total number of shares of the Company as of March...
Aveanna Files Registration Statement for Proposed Initial Public Offering
ATLANTA, April 01, 2021 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) today announced that it has filed a registration...